Adenovirus-mediated gene transfer to liver
- 1 March 2001
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 46 (1-3), 205-209
- https://doi.org/10.1016/s0169-409x(00)00125-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.Proceedings of the National Academy of Sciences, 1995
- MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenovirusesImmunity, 1994
- Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.Proceedings of the National Academy of Sciences, 1994
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.Proceedings of the National Academy of Sciences, 1994
- Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemiaNature Genetics, 1994
- Adenovirus mediated expression of therapeutic plasma levels of human factor IX in miceNature Genetics, 1993
- Gene therapy: adenovirus vectorsCurrent Opinion in Genetics & Development, 1993
- Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1–deleted adenovirusesNature Genetics, 1993
- Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx miceNature, 1993
- Long-Term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient RabbitsScience, 1991